Related Experiment Videos
[Pleural effusion following hepatic radiofrequency]
F Roy Saint-Georges1, P Mulliez, A Darras
1Service de Pneumologie, Hôpital Saint-Philibert, Lomme, France. saint-georges.francoise@ghicl.net
Revue Des Maladies Respiratoires
|November 8, 2005
Summary
Radiofrequency ablation for liver tumors can lead to delayed pleurisy, a complication respiratory physicians must recognize. Early diagnosis and management are crucial for patient outcomes.
Area of Science:
- Hepatobiliary Medicine
- Interventional Radiology
- Pulmonology
Background:
- Radiofrequency ablation (RFA) is an alternative treatment for hepatic tumors when surgery is contraindicated.
- RFA can be performed percutaneously, during laparotomy, or endoscopically.
- Respiratory physicians should be aware of potential complications associated with RFA.
Observation:
- Two cases of pleurisy following hepatic RFA are presented.
- Pleurisy developed 15 days and one month post-RFA for liver metastases.
- Effusions were exudative and predominantly lymphocytic.
Findings:
- The first case required thoracoscopy for diagnosis.
- The second case resolved with pleural aspirations.
- Pleurisy following hepatic RFA can manifest late.
Implications:
- Delayed diagnosis and treatment of post-RFA pleurisy can occur.
- Awareness of this complication is essential for respiratory physicians.
- Effective management strategies for post-RFA pleurisy are important.